Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-23-000052 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
20.40% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.36% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.25% · OPTIONAL · VALID
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
4.64% · CORE · VALID
Inventory pressure 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
15.52% · OPTIONAL · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
5.61% · CORE · VALID
R&D intensity 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.00% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.60% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 78.87%
Current 20.40%
Delta -58.47% Capex Intensity Increased
Previous 1.78%
Current 2.36%
Delta 0.57% Cash Generation Decreased
Previous 12.23%
Current 5.25%
Delta -6.98% Growth Decreased
Previous 9.73%
Current 4.64%
Delta -5.09% Inventory Pressure Decreased
Previous 59.53%
Current 15.52%
Delta -44.01% Profitability Decreased
Previous 7.16%
Current 5.61%
Delta -1.55% R And D Intensity Decreased
Previous 1.10%
Current 1.00%
Delta -0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.